XML 53 R39.htm IDEA: XBRL DOCUMENT v3.22.2
Basis of Presentation and Significant Accounting Policies - FY thru Revenue (Details)
3 Months Ended 12 Months Ended
Feb. 27, 2022
USD ($)
Point
May 28, 2022
USD ($)
Feb. 26, 2022
USD ($)
Revenue Recognition      
Measurement period   6 months  
Liability recognized into revenue   $ 713,000  
Retail Pharmacy      
Revenue Recognition      
Value of each reward point earned $ 0.002    
Minimum points required for conversion into rewards | Point 1,000    
Threshold period for expiry of unconverted points 90 days    
Threshold period for expiry of unredeemed rewards 30 days    
Accrued contract liabilities   $ 5,577,000 $ 0
Prescription files      
Intangible Assets      
Remaining Weighted Average Amortization Period   5 years 6 years
Customer relationships      
Intangible Assets      
Remaining Weighted Average Amortization Period   9 years 10 years
CMS license      
Intangible Assets      
Remaining Weighted Average Amortization Period   4 years 5 years